Oventus CEO, Dr Chris Hart commented, “As literature continues to highlight that CPAP may contribute to COVID-19 spread, effective alternative OSA treatments are being sought. Oventus technology is increasingly in the spotlight, and this is driving further demand for our Lab in Lab model from sleep groups, dentists and first responders.”
This is huge - unsure why it wasn't marked price sensitive ... but who cares
Covid_19 sales slowdown fears drove it down from 70c to the lows of 18c when Cyan was selling out
It now is evident Covid_19 will ACCELERATE their rollout / sales plans as patients are being pushed away from the incumbent CPAP treatment as CPAP spreads Corona!!